What's New
News
2021 FTSG Meeting Sees Development of FTD Treatments Gaining Ground
On December 8 and 9, 2021, AFTD held its biannual meeting of the FTD Treatment Study Group…
Spotlight on…Dr. Halima Amjad, AFTD Board of Directors
Halima Amjad, MD, MPH, knew she wanted to be a doctor since she was a child, but…
AFTD/ADDF Grantees to Study Potential FTD Treatments and Biomarkers
AFTD grants support scientists as they conduct vital research into advancing our understanding of FTD. Several newly…
Giving a Hand to Our Helping Hands! AFTD Volunteer Veronica Wolfe
When Veronica Wolfe’s mother was diagnosed with bvFTD in 2018, her family initially struggled to find information…
Experts Address Vital Research Priorities for Related Dementias at ADRD Summit 2022
The Alzheimer’s Disease-Related Dementias (ADRD) Summit convened for its fourth event to gather input from the research…
ALLFTD-Affiliated Neurologist Explains Aphasia Following Bruce Willis Diagnosis
Following actor Bruce Willis’s recently announced aphasia diagnosis, neurologist Nupur Ghoshal, MD, PhD, gave more insight into…
“Vogue” Covers AFTD’s 2022 Hope Rising Benefit
(L-R: AFTD CEO Susan L-J Dickinson, AFTD Board member Donald E. Newhouse, Hope Rising Benefit Chair David…
“Die Hard” Actor Bruce Willis Steps Away from Career Following Aphasia Diagnosis
Bruce Willis is stepping away from his acting career after experiencing health issues related to an aphasia…
Register for the AFTD 2022 Education Conference
Connect, learn, and engage at the AFTD 2022 Education Conference. Persons with FTD, care partners, families, and…
National Doctors Day Spotlight On…Joanna Dauber, D.O.
To mark National Doctors Day, we’re spotlighting Joanna Dauber, D.O., a family medicine physician and former FTD…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)